Research ArticleNeurointervention
Simultaneous Treatment with Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Acute Ischemic Stroke Within 3 Hours of Onset
S. Sugiura, K. Iwaisako, S. Toyota and H. Takimoto
American Journal of Neuroradiology June 2008, 29 (6) 1061-1066; DOI: https://doi.org/10.3174/ajnr.A1012
S. Sugiura
K. Iwaisako
S. Toyota

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Advertisement
S. Sugiura, K. Iwaisako, S. Toyota, H. Takimoto
Simultaneous Treatment with Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Acute Ischemic Stroke Within 3 Hours of Onset
American Journal of Neuroradiology Jun 2008, 29 (6) 1061-1066; DOI: 10.3174/ajnr.A1012
Jump to section
Related Articles
- No related articles found.
Cited By...
- Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?
- Endovascular therapy yields significantly superior outcomes for large vessel occlusions compared with intravenous thrombolysis: is it time to randomize?
- Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke
- Evaluation of an Intravenous-Endovascular Strategy in Patients with Acute Proximal Middle Cerebral Artery Occlusion
- Bridging Therapy in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
- The Effectiveness of Microballoon Angioplasty in Treating Middle Cerebral Artery Occlusion Beyond the Bifurcation
- Stent Placement in Acute Cerebral Artery Occlusion
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement